|
- 2017
Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s DiseaseDOI: 10.1007/s13311-017-0541-z Keywords: Cognitive aging, Levetiracetam (Keppra), Late-onset Alzheimer’s disease, Hippocampal CA3, Amnestic mild cognitive impairment (aMCI) Abstract: The online version of this article (doi:10.1007/s13311-017-0541-z) contains supplementary material, which is available to authorized users
|